Circulating Tumor DNA Analysis to Assess Risk of...

Clinical Cancer Research 2020 / 02

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC

Hellmann, Matthew D., Nabet, Barzin Y., Rizvi, Hira, Chaudhuri, Aadel A., Wells, Daniel K., Dunphy, Mark P.S., Chabon, Jacob J., Liu, Chih Long, Hui, Angela B., Arbour, Kathryn C., Luo, Jia, Preeshagu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-3418
Date:
February, 2020
File:
PDF, 601 KB
2020
Conversion to is in progress
Conversion to is failed